Armin Schwarzbach is a medical doctor and a specialist for laboratory medicine from the laboratory ArminLabs, Augsburg, Germany. He began by studying biochemistry at Hoechst AG, Frankfurt/Germany and pharmacy at the University of Mainz/Germany in 1984. In 1985, he studied medicine for 6 years at the University of Mainz/Germany and finished his MD in 1991. He developed the worldwide first radioimmunoassay (RIA) for human Gastric Inhibitory Polypeptide (hGIP) from 1986 – 1991, getting his Ph.D in 1992. He is member of the Swiss Association for tick-borne diseases, the German Association of Clinical Chemistry and Laboratory Medicine and the German Society for Medical Laboratory Specialists. He is an advisory board member of AONM London, England and Board Member of German Borreliosis Society and member & former board member of the International Lyme and associated diseases society (ILADS) and has served as an expert on advisory committees on Lyme Disease in England, Australia, Canada, Ireland, France and Germany. He is the Founder and CEO of ArminLabs, Augsburg/Germany and is specialized in diagnostic tests and treatment options for patients with tick-borne diseases for over 15 years. Armin Schwarzbach is a medical doctor and a specialist for laboratory medicine from the laboratory ArminLabs, Augsburg, Germany. He began by studying biochemistry at Hoechst AG, Frankfurt/Germany and pharmacy at the University of Mainz/Germany in 1984. In 1985, he studied medicine for 6 years at the University of Mainz/Germany and finished his MD in 1991. He developed the worldwide first radioimmunoassay (RIA) for human Gastric Inhibitory Polypeptide (hGIP) from 1986 – 1991, getting his Ph.D in 1992. He is member of the Swiss Association for tick-borne diseases, the German Association of Clinical Chemistry and Laboratory Medicine and the German Society for Medical Laboratory Specialists. He is an advisory board member of AONM London, England and Board Member of German Borreliosis Society and member & former board member of the International Lyme and associated diseases society (ILADS) and has served as an expert on advisory committees on Lyme Disease in England, Australia, Canada, Ireland, France and Germany. He is the Founder and CEO of ArminLabs, Augsburg/Germany and is specialized in diagnostic tests and treatment options for patients with tick-borne diseases for over 15 years.

Earth Science and Climate Change